Genenta Science
GNTA
5 hedge funds and large institutions have $1.92M invested in Genenta Science in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
1.77% less ownership
Funds ownership: 4.64% → 2.88% (-1.8%)
48% less capital invested
Capital invested by funds: $3.67M → $1.92M (-$1.76M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$1.69M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.27K |
| 3 |
Morgan Stanley
New York
|
-$2.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank Julius Baer & Co
Zurich,
Switzerland
| $1.44M | -$1.69M | -412,547 | -52% |
|
|
A
2
Allianz
Munich,
Germany
| $326K | +$382K | +93,200 | New |
|
|
AU
3
Algebris (UK)
London,
United Kingdom
| $146K | – | – | – |
|
|
4
Morgan Stanley
New York
| $1.75K | -$2.05K | -500 | -50% |
|
|
5
UBS Group
Zurich,
Switzerland
| $144 | -$9.27K | -2,260 | -98% |
|
GNTA Hedge Fund Activity: Q1 2024 in Review
5 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q1 2024, worth a combined $1.92M — down 48% from $3.67M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GNTA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest seller was Bank Julius Baer & Co, cutting an estimated $1.69M.
- 5 institutional investors held Genenta Science (GNTA) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $1.92M of Genenta Science stock for Q1 2024, down 48% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Genenta Science seller in Q1 2024 was Bank Julius Baer & Co, an estimated $1.69M sold.
Based on aggregated 13F filings for Q1 2024.